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• Periprosthetic shoulder infection (PSI) is rare but poten-
tially devastating. The rate of PSI is increased in cases of 
revision procedures, reverse shoulder implants and co-
morbidities. One specific type of PSI is the occurrence of 
low-grade infections caused by non-suppurative bacteria 
such as Propionibacterium acnes or Staphy/ococcus epide-
mermidis. 
• Success of treatment depends on micro-organism iden-
tification, appropriate surgical procedures and antibiotic 
administration efficiency. Post-operative early PSI can 
be treated with simple debridement, while chronic PSI 
requires a one- or two-stage revision procedure. Indica-
tion for one-time exchange is based on pre-operative 
identification of a causative agent. Resection arthroplasty 
remains an option for low-demand patients or recalcitrant 
infection. 
Keywords: infection; arthroplasty; shoulder; Propionibacte-
rium acnes; revision 
Introduction 
While more than 66000 prosthetic shoulder procedures 
were performed in 2011 in the United States, the rate of 
post-operative infection seems to remain stable with 
0.98% of cases.1·3 However, when infection occurs, this 
complication is always devastating with significant clinical 
and socioeconomic consequences.2 The rate is higher 
after revision surgery than after a primary procedure and 
reaches close to 5% in cases of reverse shou lder arthro-
plasty (RSA).4•5 Patients undergoing primary RSA are 
found to have a six times greater risk of infection com-
pared with patients having primary unconstrained total 
shoulder arthroplasty.6 Arthroplasties for trauma are more 
at risk of infection than those from other causes.6 Comor-
bidities such as coagulopathy, renal failure, diabetes, 
lupus erythematosus, rheumatoid arthritis, intra-articular 
steroid injections and corticosteroid therapy increase the 
risk of periprosthetic shoulder infection (PSl).7 PSI is the 
major cause for revis ion within the first two post-operative 
years after an arthroplasty.8 
The aim of this review is to investigate PSI from diagno-
sis to prevention and to report the main results of different 
therapeutic options. 
Microbiology 
The micro-organisms most commonly isolated in cases of 
PSI are Staphylococcus (S.) aureus, S. epidermidis and Propi-
onibacterium (P.) acnes.9 P. acnes is a gram-positive anaer-
obic bacillus, much more concentrated in the axilla than 
in the knee or hip.10 Different studies have identified a 
presence of P. acnes in the operative field during primary 
surgery, despite rigorous skin preparation and timely 
administered prophylactic antibiotics.11 -13 lt colonises the 
pilosebaceous follic les and there is a likelihood of finding 
it in the dermal layer, in male patients and after corticoid 
injection.12-14 Hudek et al1 4 identified a positive culture 
twofold greater for the anterolateral approach than for the 
deltopectoral approach. Surprisingly, it is even thought to 
be involved in the pathogenesis of glenohumeral osteoar-
thritis.11 lt is often responsible for low-grade infection, 
with mild clinical symptoms, so that many classic clinical 
patterns do not strictly apply. The mean duration for cul-
ture incubation is between seven and > 21 days. 
Prevention 
Antibiotic prophylaxis is not specific to shoulder arthro-
plasty compared w ith other arthroplasties. lntravenous 
cephalosporine (2 g) administration is mandatory, given 
30 minutes before the skin incision in many countries. 
However, some authors recommend a single 160 mg of 
gentamicin by intra-articular injection at the end of the 
procedure to reduce the risk of PSI.15
Saltzman et al16 have shown that pre-operative prepa-
ration of the surgical site with ‘ChloraPrep’ 2% (chlorhex-
idine gluconate and 70% isopropyl alcohol; ChloraPrep, 
Leawood, Kansas) was more effective than ‘DuraPrep’ 
(iodine povacrylex and 74% isopropyl alcohol; 3M, Min-
neapolis, Minnesota) and povidone-iodine (Purdue 
Pharma, Stamford, Connecticut) at eliminating overall 
bacteria, and that ChloraPrep and Duraprep were more 
effective than povidone-iodine regarding coagulase- 
negative Staphylococcus.
Hair removal is commonly performed before orthopae-
dic procedures and the use of razors is classically discour-
aged because micro-abrasions are created by shaving. 
However, removal of axillary hairs for shoulder surgery did 
not prove to have any effect on the cell-count of P. acnes 
before surgical preparation.17
Diagnosis
Classically, post-operative infections can be classified into 
acute infection (one to three months), subacute infection 
(four to 12 months) and late infection (> 12 months), 
depending on the time of diagnosis after the surgery.18 
However, some authors advocate the distinguishing of 
early and late infection (cutoff at six weeks), so that there 
is a real chance to save the index prosthesis by avoiding 
any delay.19
One specific type of PSI is low-grade infections by non-
suppurative bacteria such as P. acnes or S. epidemermidis.20,21 
Diagnosis remains a challenge because P. acnes does not 
usually cause swelling, erythema, fever, purulent dis-
charge or increasing level of biological parameters such as 
C-reactive protein (CRP), white blood cell count (WBC)
and interleukin (IL)-6. Aspiration of synovial fluid is man-
datory if a distinct fluid collection is identified (with positive
serum levels giving positive findings of WBC > 3000/mm3
and > 80% for polymorphonuclear neutrophils). Also,
deep biopsies that contact the prosthesis are needed.22-24
Performing five to six independent samples in order to
optimise the sensitivity and specificity for the diagnosis of
a PSI has been advocated. The cutoff for a definite diag-
nostic of infection should be three or more samples
positive to the same micro-organism.24 The concern is that 
the growth duration from intra- operative samples is long 
for P. acnes, and every laboratory should be aware that 
they should not discard the culture samples early. How-
ever, early positive cultures seem to be more predictive of 
a true infection than a late growth culture, which can be a 
false-positive result.20
On the other hand, in the case of a virulent micro-
organism, patients with PSI can also present classical 
symptoms including a painful shoulder with local and/or 
systemic physical signs. The blood tests reveal the same 
non-specific inflammatory markers that can be identified 
in a knee or hip prosthetic infection. Obviously, erythro-
cyte sedimentation, as well as CRP, have a poor sensitivity 
for the diagnosis of an infected arthroplasty in the post-
operative setting, even if the CRP is normalised two weeks 
after an uneventful procedure.25
As proposed by a workgroup from the Musculoskeletal 
Infection Society focused on lower limb arthroplasty infec-
tions, the diagnosis should be based on a combination of 
biological and clinical criteria (Table 1).26
Treatment
Superficial wound infections are usually diagnosed in 
post-operative care and require local measures and anti-
biotic therapy. However, it is always necessary to suspect 
a deep infection and the patient should be treated as such 
until proven otherwise. In this potentially serious situa-
tion, success depends on early identification of micro-
organisms, appropriate surgical procedures and efficient 
antibiotic administration. Different therapeutic options 
are available: debridement, simple resection arthroplasty, 
removal of the prosthesis and replacement with a cement 
spacer (spacer), single-stage revision, two-stage revision, 
arthrodesis, chronic antibiotic administration and even 
amputation. The outcomes of some of these options are 
described below.
Debridement
Debridement, irrigation and multiple deep samples may be 
proposed in cases of acute infection in order to save the 
prosthesis. Coste et al27 treated eight cases of acute infection 
with debridement and succeeded when it was performed 
Table 1. Criteria of Musculoskeletal Infection Society (MSIS) for retaining the prosthesis in periprosthetic infection26
There is a sinus tract communicating with the prosthesis; or
A pathogen is isolated by culture from at least two separate tissue or fluid samples obtained from the affected prosthetic joint; or
Four of the following criteria exist:
1. Elevated serum erythrocyte sedimentation rate and serum C-reactive protein concentration,
2. Elevated synovial leukocyte count,
3. Elevated synovial neutrophil percentage,
4. Presence of pus in the affected joint,
5. Isolation of a micro-organism in one culture of periprosthetic tissue or fluid, or
6. Greater than five neutrophils per high-power field in five high-power fields observed from histological analysis of peri-prosthetic tissue at ×400 
magnification.
within eight days after the diagnosis. They concluded that 
the earlier the debridement is done, the more effective it is in 
eradicating the infection. This procedure can be repeated, 
based on the patient’s response.28 Moreover, mobile parts 
of the prosthesis may be exchanged during the procedure 
especially in case of RSA (glenosphere, polyethylene liner) 
providing better access for debridement. Then, an appropri-
ate antibiotics regime is required for a minimum of four 
weeks.21,28,29 However, the rate of success reported in the 
literature is only in the range of 50% to 95%.22,27-29
Cement spacer
An antibiotic-loaded cement spacer can be used either per-
manently or as the first step of a two-stage revision proce-
dure. In this case, it maintains the space and soft-tissue 
tension for re-implantation and theoretically releases anti-
biotics to decrease the growth of microorganisms. Anti-
biotic mean concentration peak is reached at day 1 and 
dramatically decreases during the following seven days.30
Levy et  al31 described a ‘functional cement spacer’ 
model, which is made of a hemi-arthroplasty coated with 
cement. In their series of 14 patients initially chosen for a 
two-stage procedure, nine did not undergo a prosthesis 
re-implantation because of satisfactory clinical outcomes. 
On the other hand, verhelst et al32 did not prove any differ-
ence between patients with a cement spacer and resection 
arthroplasty regarding infection control and clinical out-
comes. Complications of the cement-spacer such as break-
age, glenoid erosion or dislocation have been reported.32
One-stage revision arthroplasty
Based on the experience of knee and hip infection man-
agement, a single-stage exchange is proposed as a rea-
sonable option when the infecting micro-organism is 
satisfactiorily identified. The advantages are a reduced 
hospital stay, costs, period of antibiotic administration 
and the best clinical outcomes (Table 2).9,22,27,29,33-37
Klatte et  al33 reported the outcomes of the largest 
single- centre series of 35 patients with a mean follow-up 
of 4.7 years. The authors excised infected tissues, 
thoroughly irrigated the wound using pulsatile lavage 
with polyhexanide before re-implantation and delivered 
specific intravenous antibiotherapy for an average of two 
weeks post-operatively. The success rate was more than 
90%. No recurrence was observed in the series of Coste 
et al,27 Ince et al34 and Cuff et al.35 The presence of a pro-
ductive fistula seems not to be a contra-indication for 
many authors.33,36 Beekman et al36 performed a one-stage 
revision in 11 cases of RSAs, among which eight had a fis-
tula, and achieved a success rate of 90%.
Two-stage revision arthroplasty
In a medically stable patient with a high demand, a two-
stage revision procedure is generally accepted (Table 
3).22,27,29,33,38-40 It is highly recommended when the micro-
organism responsible for the infection is unknown. The 
first step consists of infection eradication after prosthetic 
removal: an antibiotic-loaded cement spacer is often 
implanted and general antibiotics are administrated, sec-
ondarily adapted to the micro-organism(s) identified. Anti-
biotics are generally continued for six to eight weeks. 
Markers such as CRP or IL-6 have been shown to be valua-
ble to predict the eradication of infection and, so, the time 
of re-implantation.41,42 However, IL-6 seems to be normal-
ised faster than CRP and allows earlier revision for better out-
comes.41 An iterative irrigation and debridement could be 
proposed in case of persistent infection. For re- implantation, 
RSA has been gaining ground in recent years as the implant 
of choice. First, it allows a larger debridement at the first 
stage with less concern for soft-tissue preservation. Sec-
ondly, it offers the possibility of addressing the glenoid 
bone defect with or without bone graft. Shirwaiker et al43 
reported that there is still uncertainty whether two-stage 
revision is superior to one-stage (Fig. 1).
Resection arthroplasty
Shoulder resection should remain a salvage procedure 
for frail or low-demand patients, and recalcitrant infec-
tion. It offers the option of a single definitive procedure 
Table 2. One-stage revision arthroplasty (RSA, reverse shoulder arthro-
plasty; HA, hemiarthroplasty; TSA, total shoulder arthroplasty; Bip, bipolar 
arthroplasty)
Reference n Mean follow-up
(yrs)
Type of infected 
prosthesis
Rate of 
success (%)
Klatte et al33 35 4.7 RSA, HA, Bip 94
Grosso et al37 17 3 RSA, TSA, HA 94.1
Beekman et al36 11 2 RSA 91
Ince et al34 9 5.8 TSA, HA 100
Cuff et al35 7 3.6 TSA, HA 100
Coste et al27 3 2.7 TSA, HA 100
Jacquot et al21 5 3 RSA 100
Table 3. Two-stage revision prosthesis (RSA, reverse shoulder arthro-
plasty; HA, hemiarthroplasty; TSA, total shoulder arthroplasty)
Reference n Mean follow-up 
(yrs)
Type of infected 
prosthesis
Rate of 
success (%)
Strickland et al38 19 2.9 HA, TSA 63
Romanò et al29 17 3.8 RSA, HA 100
Sabesan et al40 17 3.8 RSA, TSA, HA 94
Jacquot et al21 14 3 RSA 64
Ortmaier et al39 12 6.1 RSA 75
Coste et al27 10 2.6 TSA, HA 60
Cuff et al35 10 3.6 HA 100
Fig. 2 Radiographs (a and b) of an 86-year-old woman, with a loose implant secondary to chronic periprosthetic shoulder infection. 
c) Because of numbers of co-morbidities and huge bone loss on glenoid side, a simple resection arthroplasty was performed.
for infection eradication (Fig. 2). It has been shown that 
functional results are poor, but pain relief is achieved in 
more than 50% of cases.9,44 Rispoli et al44 reported a mean 
active elevation of 70° at long-term follow-up after ‘ana-
tomical’ shoulder arthroplasty removal. verhelst et  al32 
demonstrated that preservation of the tuberosities is a 
predictive factor for better results, because it can avoid 
antero- superior subluxation of the humerus. In cases of 
RSA, Jacquot et al21 did not improve functional outcomes 
after removal of the implant and identified a high rate of 
post-operative complications. Bone loss and soft-tissue 
impairment after such constrained prostheses could partly 
explain these findings. Despite Jacquot21 and Coste’s27 
studies, the literature reports a high rate of infection eradi-
cation, reaching more than 90% of cases.9,27,29,32,44,45
Conclusions
PSIs are a rare but remain a devastating complication in 
terms of functional outcomes. Acute infection (less than 
two months post-operatively) requires prosthetic washout 
as soon as possible, and the exchange of the mobile part 
of the implant. However, the important point in manag-
ing PSI is the high rate of low-grade infections that must 
be suspected in cases with abnormal clinical outcomes 
including pain and stiffness. It is often considered as sub-
acute or chronic infection because of a ‘wait and see’ 
approach by the practitioner.46 In this situation, S. epider-
midis or P. acnes are frequently involved and a simple 
debridement is too late. One-stage revision is possible if 
the micro-organism is identified pre-operatively, other-
wise a two-stage procedure is recommended. Resection 
arthroplasty remains the option for low-demand patients. 
A multidisciplinary collaboration is nowadays recom-
mended to optimise the antibiotic treatment and the sur-
gical procedure.
Fig. 1 a) Radiograph of a 73-year-old man with a chronic periprosthetic shoulder infection of a reverse shoulder arthroplasty (RSA). 
b) A two-stage revision was decided with a cement spacer implantation for eight weeks. c) Propionibacterium acnes was identified on
peri-operative samples taken from the back of the glenosphere. d) After four weeks free of antibiotics, a new RSA was implanted with
a proximal humeral allograft.
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